3Treede RD, Jensen TS, Campbell JN, et al. Neuropathi pain: redefinition and a grading system for clinical and research purposes. Neurology. 2008,70:1630 - 5.
4Bouhassira D, Lanteri -Minet M, Attal N, et al. Preva- lence of chronic pain with neuropathic characteristics in the general population. Pain. 2008,136:380 - 7.
5Relieving Pain in America: A Blueprint for Transforming Prevention, Care, Education, and Research. Washington DC : National Academy of Sciences. 2011.
6Durisova M, Dedik L. New mathematical methods in phar- maeokinetic modeling. Basic & clinical pharmacology & toxicology. 2005,96 : 335 - 42.
7Rintala DH, Holmes SA, Courtade D, et al. Comparison of the effectiveness of amitriptyline and gabapentin on chro- nic neuropathic pain in persons with spinal cord injury. Archives of physical medicine and rehabilitation. 2007, 88 ~ 1547 - 60.
8Otto M, Bach FW, Jensen TS, et al. Escitalopram in painful polyneuropathy : a randomized, placebo - con- trolled, cross - over trial. Pain. 2008,139:275 - 83.
9Dworkin RH, O' Connor AB, Backonja M, et al. Pharma- cologic management of neuropathic pain: evidence - based recommendations. Pain. 2007,132:237 - 51.
10Attal N, Cruccu G, Baron R, et al. EFNS guidelines on the pharmacological treatment of neuropathic pain: 2010 revision. European journal of neurology. 2010, 17:1113 - e88.
